Add to ORKGParticle size and shape are critical quality attributes for active pharmaceutical ingredients (API) as they have direct impact on downstream processing, as well as on the performance behaviour of the finished product. Obtaining a reliable and robust quantitative information of these particle attributes in real-time remains a great challenge across the multiple manufacturing steps and cannot be achieved by just using a single sensor
In this paper we present a novel measurement technique for monitoring particle size distributions of...
Sample complexity and polydispersity presents challenges surrounding particle size measurements for ...
Hypothesis: The implementation of the proposal from the European Chemical Agency (ECHA) to restrict ...
IntroductionParticle size and shape are critical quality attributes for active pharmaceutical ingred...
Size and shape distributions are among critical quality attributes of particulate products and their...
Particle size and shape are critical quality attributes for active pharmaceutical ingredients (API) ...
Within the pharmaceutical industry, particle size and shape distributions are crucial properties of ...
Particle size distribution is vitally important in pharmaceutical formulation. Spectroscopy is the m...
We study means of extracting quantitative information about particle attributes using state-of-art i...
Particle size and shape are important in the pharmaceutical industry, affecting both process efficie...
Digitisation of manufacturing processes under the umbrella of Industry 4.0 is a multi-faceted challe...
peer reviewedThis paper highlights the fact that particle size distribution (PSD) is not unique for ...
Crystallization control can be improved through real-time monitoring technologies. Here, a workflow ...
Improving the data descriptor calculation of crystal’s physical properties requires sophisticated im...
International audienceThis article presents a new in situ method to monitor the particle size distri...
In this paper we present a novel measurement technique for monitoring particle size distributions of...
Sample complexity and polydispersity presents challenges surrounding particle size measurements for ...
Hypothesis: The implementation of the proposal from the European Chemical Agency (ECHA) to restrict ...
IntroductionParticle size and shape are critical quality attributes for active pharmaceutical ingred...
Size and shape distributions are among critical quality attributes of particulate products and their...
Particle size and shape are critical quality attributes for active pharmaceutical ingredients (API) ...
Within the pharmaceutical industry, particle size and shape distributions are crucial properties of ...
Particle size distribution is vitally important in pharmaceutical formulation. Spectroscopy is the m...
We study means of extracting quantitative information about particle attributes using state-of-art i...
Particle size and shape are important in the pharmaceutical industry, affecting both process efficie...
Digitisation of manufacturing processes under the umbrella of Industry 4.0 is a multi-faceted challe...
peer reviewedThis paper highlights the fact that particle size distribution (PSD) is not unique for ...
Crystallization control can be improved through real-time monitoring technologies. Here, a workflow ...
Improving the data descriptor calculation of crystal’s physical properties requires sophisticated im...
International audienceThis article presents a new in situ method to monitor the particle size distri...
In this paper we present a novel measurement technique for monitoring particle size distributions of...
Sample complexity and polydispersity presents challenges surrounding particle size measurements for ...
Hypothesis: The implementation of the proposal from the European Chemical Agency (ECHA) to restrict ...